Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for prevention of cytarabine-induced thrombocytopenia in lymphoma
NCT04797182Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in Thrombocytopenia, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT04797182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797182.